# PRR15

## Overview
PRR15 (proline rich 15) is a gene that encodes a nuclear protein involved in critical cellular processes, particularly in the context of placental development and cancer. The PRR15 protein is characterized by its proline-rich composition, which suggests a role in protein-protein interactions, potentially acting as a co-activator or co-repressor of transcription. It is notably expressed in the human placenta during the first trimester, where it plays a vital role in maintaining the balance between cell proliferation and apoptosis, essential for healthy placental development (Gates2017Effect). In cancer biology, PRR15 interacts with key signaling pathways, such as the PI3K/Akt pathway, influencing tumorigenesis and metastasis, particularly in triple-negative breast cancer (Guo2023PRR15). Alterations in PRR15 expression have been linked to various pathological conditions, including placental disorders and colorectal cancer, highlighting its potential as a biomarker for disease progression (Meunier2010Expression).

## Function
PRR15 (proline rich 15) is a nuclear protein expressed in the human placenta during the first trimester, particularly in trophoblast-derived cell lines. It plays a crucial role in early placentation by maintaining a balance between cell proliferation and apoptosis, which is essential for healthy placental development (Gates2017Effect). PRR15 deficiency in trophoblast cells leads to significant changes in gene expression, particularly affecting pathways related to cell proliferation, apoptosis, and the cell cycle. This includes a reduction in pro-proliferative genes and an increase in anti-proliferative genes, as well as down-regulation of the insulin-like growth factor (IGF) signaling axis, which is important for cell growth and proliferation (Gates2017Effect).

PRR15 also appears to protect cells from excessive apoptosis, a process that, while necessary for normal placental development, can lead to complications such as preeclampsia and intrauterine growth restriction if unregulated (Gates2017Effect). The protein's nuclear localization suggests it may function as a co-activator or co-repressor of transcription, influencing mRNA processing and gene expression related to cell survival and differentiation (Gates2017Effect).

## Clinical Significance
Alterations in the expression of the PRR15 gene have been implicated in several diseases, particularly in the context of cancer and placental disorders. In triple-negative breast cancer (TNBC), PRR15 expression is significantly lower compared to non-TNBC and normal tissues. This downregulation is associated with more aggressive clinical features, higher metastasis rates, and poorer prognosis. PRR15 deficiency in TNBC facilitates malignant progression by mediating the PI3K/Akt signaling pathway, promoting epithelial-mesenchymal transition (EMT), and increasing sensitivity to certain anticancer drugs. Low PRR15 expression in TNBC is linked to higher clinical stages and increased metastasis, particularly in the central nervous system (Guo2023PRR15).

In the context of placental development, PRR15 plays a crucial role in trophoblast viability and survival during early pregnancy. PRR15 deficiency in trophoblast cells leads to decreased cell proliferation and increased apoptosis, which may contribute to placental disorders such as preeclampsia and intrauterine growth restriction (IUGR). The deficiency results in significant changes in gene expression related to cell cycle regulation, survival, and apoptosis, potentially impairing placental development and function (Gates2017Effect).

In colorectal cancer, PRR15 expression is associated with advanced tumor stages and may serve as a marker for tumor progression, although its exact role in tumorigenesis requires further investigation (Meunier2010Expression).

## Interactions
PRR15 (proline rich 15) is involved in various cellular interactions, particularly in the context of cancer and placental development. In triple-negative breast cancer (TNBC), PRR15 interacts with the PI3K/Akt signaling pathway. Its deficiency leads to the activation of this pathway, which is associated with increased tumorigenesis and metastasis. This interaction suggests that PRR15 may play a role in modulating the PI3K/Akt pathway, influencing cancer progression and drug response (Guo2023PRR15).

In trophoblast cells, PRR15 deficiency results in significant changes in gene expression related to cell cycle regulation, survival, and apoptosis. This includes the upregulation of TNFSF10, a factor inducing apoptosis, and alterations in the expression of genes involved in cell migration and invasion, such as IGF1R and IGFBP3. These changes indicate that PRR15 may act as a co-activator or co-repressor of transcription, influencing mRNA processing rather than directly affecting gene transcription (Gates2017Effect).

PRR15 does not contain known DNA binding motifs, suggesting its interactions are likely mediated through protein complexes or signaling pathways rather than direct DNA binding (Gates2017Effect).


## References


[1. (Gates2017Effect) Katherine C. Gates, Lindsey N. Goetzmann, Jeremy D. Cantlon, Kimberly M. Jeckel, and Russell V. Anthony. Effect of proline rich 15-deficiency on trophoblast viability and survival. PLOS ONE, 12(4):e0174976, April 2017. URL: http://dx.doi.org/10.1371/journal.pone.0174976, doi:10.1371/journal.pone.0174976. This article has 15 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0174976)

[2. (Guo2023PRR15) Fengzhu Guo, Jialu Ma, Cong Li, Shuning Liu, Weizheng Wu, Chunxiao Li, Jiani Wang, Jinsong Wang, Zhijun Li, Jingtong Zhai, Fangzhou Sun, Yantong Zhou, Changyuan Guo, Haili Qian, and Binghe Xu. Prr15 deficiency facilitates malignant progression by mediating pi3k/akt signaling and predicts clinical prognosis in triple-negative rather than non-triple-negative breast cancer. Cell Death &amp; Disease, April 2023. URL: http://dx.doi.org/10.1038/s41419-023-05746-8, doi:10.1038/s41419-023-05746-8. This article has 1 citations.](https://doi.org/10.1038/s41419-023-05746-8)

[3. (Meunier2010Expression) Dominique Meunier, Kalicharan Patra, Ron Smits, Andrea Hägebarth, Angela Lüttges, Rolf Jaussi, Matthew J. Wieduwilt, Leticia Quintanilla‐Fend, Heinz Himmelbauer, Riccardo Fodde, and Reinald H. Fundele. Expression analysis of proline rich 15 (prr15) in mouse and human gastrointestinal tumors. Molecular Carcinogenesis, 50(1):8–15, November 2010. URL: http://dx.doi.org/10.1002/mc.20692, doi:10.1002/mc.20692. This article has 13 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/mc.20692)